Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week
NCT00537888 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2010-12-14
Summary
The definition of pulmonary candidiasis is still unclear.In China, isolation of candida spp. form sputum twice or three times a week has been regarded as the microbiological evidence of pulmonary candidiasis. The investigators hypothesize that patients who present respiratory symptoms and lung infiltrates together with smear of culture positive for candida spp. from sputum three times a week can not be diagnosed as pulmonary candidiasis.
Conditions
- Pulmonary Candidiasis
Interventions
- DRUG
-
fluconazole
Intravenous or oral 400 md/d
Sponsors & Collaborators
-
Capital Medical University
lead OTHER
Principal Investigators
-
Bin Cao, Doctor · Beijing Chaoyang Hospital, Affiliate of Capital Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 14 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
- Primary Completion
- 2010-12-31
- Completion
- 2011-12-31
Countries
- China
Study Locations
More Related Trials
-
Value of PCT When Diagnosing Candidemia
NCT05385107 ·Status: COMPLETED
-
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
NCT02678598 ·Status: COMPLETED
-
Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients
NCT00304772 ·Status: WITHDRAWN ·Phase: PHASE4
-
Population Pharmacokinetics of Fluconazole in the Treatment of Neonatal Fungal Infectious Disease
NCT05775692 ·Status: UNKNOWN
-
A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated Candidemia
NCT06907992 ·Status: NOT_YET_RECRUITING
-
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
NCT00000744 ·Status: COMPLETED ·Phase: NA
-
Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis
NCT00004808 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
NCT01982071 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
NCT00002339 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
NCT00002304 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
NCT00004938 ·Status: COMPLETED ·Phase: PHASE2
-
The Study Of Fluconazole For Vulvovaginal Candidiasis
NCT01806623 ·Status: COMPLETED ·Phase: PHASE3
-
Changing Patterns of Candida Infections in Urban Medical Centers
NCT00366223 ·Status: COMPLETED
-
Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy
NCT00002038 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Candidiasis
NCT05074602 ·Status: UNKNOWN ·Phase: PHASE3
-
An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections
NCT01823289 ·Status: COMPLETED ·Phase: PHASE4
-
Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp
NCT02646800 ·Status: TERMINATED ·Phase: PHASE4
-
Retrospective Chart Review of Candida Fungemia
NCT03827330 ·Status: COMPLETED
-
A Randomized Study of a Short Duration Therapy for Candidemia
NCT06859671 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS
NCT00002282 ·Status: COMPLETED ·Phase: NA
-
The Assessment of Antimicrobial Peptides Against Fungal Infection
NCT05368948 ·Status: UNKNOWN
-
A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)
NCT00635648 ·Status: COMPLETED ·Phase: PHASE3
-
Anidulafungin In Treatment Of Candidemia In Asian Subjects
NCT00537329 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis
NCT02646774 ·Status: TERMINATED ·Phase: PHASE4